Loading...
Aleafia Health Inc.
AH.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.02
CA$0.005(33.33%)

Over the past four quarters, Aleafia Health Inc. demonstrated steady revenue growth, increasing from $12.03M in Q1 2022 to $9.39M in Q4 2022. Operating income reached -$7.36M in Q4 2022, maintaining a consistent -78% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$6.47M, reflecting operational efficiency. Net income rose to -$14.43M, with EPS at -$0.04. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan